Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Herpes Simplex Virus Glycoprotein D Associated with Aβ<sub>1-42</sub> Tetramers Mediates Neurotoxicity by Perturbing Neuronal Membrane Integrity: A Molecular Dynamics Simulation.

ACS chemical neuroscience·2025
Same author

Molecular Dynamic Simulations for Biopolymers with Biomedical Applications.

Polymers·2024
Same author

Calcium inhibits penetration of Alzheimer's Aβ<sub>1</sub> -<sub>42</sub> monomers into the membrane.

Proteins·2022
Same author

Insight on the interaction between the scorpion toxin blocker Discrepin on potassium voltage-gated channel Kv4.3 by molecular dynamics simulations.

Journal of biomolecular structure & dynamics·2022
Same author

Membrane fluidity, composition, and charge affect the activity and selectivity of the AMP ascaphin-8.

Biophysical journal·2022
Same author

Imidazole and nitroimidazole derivatives as NADH-fumarate reductase inhibitors: Density functional theory studies, homology modeling, and molecular docking.

Journal of computational chemistry·2022

Related Experiment Video

Updated: Jun 12, 2025

Preparation of Oligomeric &#946;-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

23.2K

A Small Molecule Impedes the Aβ1-42 Tetramer Neurotoxicity by Preserving Membrane Integrity: Microsecond Multiscale

Subramanian Boopathi1,2, Ramón Garduño-Juárez2

  • 1Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India.

ACS Chemical Neuroscience
|September 18, 2024
PubMed
Summary

The small molecule M30 binds to amyloid-beta (Aβ) oligomers, forming a stable complex that prevents Aβ from damaging neuronal membranes. This discovery offers a potential new therapeutic strategy for Alzheimer's disease (AD).

Keywords:
Alzheimer’s diseaseamyloid beta peptidemembraneneurotoxicitysmall molecule

More Related Videos

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
00:15

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

5.9K
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.3K

Related Experiment Videos

Last Updated: Jun 12, 2025

Preparation of Oligomeric &#946;-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
04:41

Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices

Published on: July 14, 2010

23.2K
Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
00:15

Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils

Published on: September 28, 2019

5.9K
Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
10:19

Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps

Published on: August 14, 2016

9.3K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Computational Biology

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaques, but soluble Aβ oligomers are more toxic to neurons.
  • Current AD treatments removing Aβ fibrils have not halted disease progression, highlighting the need for new therapeutic targets.
  • Developing compounds to mitigate Aβ oligomer toxicity is crucial for an effective Alzheimer's cure.

Purpose of the Study:

  • To investigate the impact of the small molecule M30 on Aβ₁-42 tetramer structure and its interaction with neuronal membranes.
  • To determine if M30 can prevent Aβ₁-42 oligomers from causing membrane damage and neuronal cell death.

Main Methods:

  • Utilized multiscale all-atom (AA)/coarse-grained (CG) molecular dynamics (MD) simulations in an explicit solvent model.
  • Simulated Aβ₁-42 tetramers with and without M30 in contact with a DMPC lipid bilayer.
  • Analyzed structural changes, membrane interactions, and complex stability over 70-μs simulation time.

Main Results:

  • Unbound Aβ₁-42 tetramers penetrated the DMPC bilayer, disrupting membrane integrity.
  • Aβ₁-42 tetramers bound with M30 (Aβ₁-42-M30 complexes) did not penetrate the membrane.
  • M30 binding induced hydrogen bonds, creating a stable, rigid Aβ₁-42-M30 complex that prevented membrane interaction and damage.

Conclusions:

  • M30 binding to Aβ₁-42 tetramers forms a rigid complex that prevents membrane disruption.
  • These findings support M30's potential to prevent synaptotoxicity and improve cognitive function in Alzheimer's disease.
  • M30 represents a promising therapeutic candidate for Alzheimer's disease by targeting toxic Aβ oligomers.